Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Lodewyk F. A. Wessels
Based on 51 articles published since 2009
(Why 51 articles?)
||||
Expertise Level
The expertise of Lodewyk F. A. Wessels ranks in the
  • Top 0.56%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 51 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Wessels, Lodewyk F   ·   Wessels, Lodewyk F A   ·   Wessels, L F A   ·   Wessels, L   ·   Wessels, Lodewyk
Work Locations
Details
Most likely:    Leeuwenhoek Hospital      
2019
  • Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Utrecht, the Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, Ghent University Hospital, Ghent, Belgium. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · NanoString Technologies, Inc., Seattle, WA, USA. · Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium. · Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia. · Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 31086347
  • Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Transgenic Core Facility, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · ACRF Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. · Department of Medical Biology, University of Melbourne, Parkville, VIC, 3010, Australia. · Preclinical Intervention Unit, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Medicine, University of Medicine, Parkville, VIC, 3010, Australia. · Parkville Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, VIC, 3050, Australia. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 30674894
2018
  • Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Pubmed 30379847
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 30115694
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden 2333 ZC, the Netherlands. · Institute of Molecular Cancer Research, University of Zurich, Zurich CH-8057, Switzerland. · Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9723GZ, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Division of Cell Biology and BioImaging Facility, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK. · Danish Cancer Society Research Center, Copenhagen 2100, Denmark; Karolinska Institute, Department of Medical Biochemistry and Biophysics, Division of Genome Biology, Science for Life Laboratory, Stockholm 171 77, Sweden. · Danish Cancer Society Research Center, Copenhagen 2100, Denmark. · Pathology Department, Complejo Hospt. Univ. Insular Materno Infantil, Las Palmas, Gran Canaria, Spain. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. Electronic address: · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern 3012, Switzerland. Electronic address: · Pubmed 29894693
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Genomic Sequencing Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Cancer and Haematology, The Walter and Eliza Hall Institute, Parkville Victoria, Australia. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Pubmed 29844118
  • Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 2QQ, UK. · Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Pubmed 29795445
  • Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center, 3584 CX, Utrecht, The Netherlands. · Dutch Breast Cancer Research Group, (BOOG Study Center), 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer Genomics Netherlands, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. · Department of Pathology, VU Medical Center (VUMC), 1081 HV, Amsterdam, The Netherlands. · Division of Oncology and Pathology, Lund University, 221 00, Lund, Sweden. · Department of Pathology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands. · Department of Pathology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Faculty of EEMCS, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 29396493
  • Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 29326437
  • Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands. · Cell Screening Core, Department of Cell Biology, Center for Molecular Medicine, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Pharmacology and Translational Research, Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, 1121 Vienna, Austria. · Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands; Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Länggassstrasse 122, 3012 Bern, Switzerland. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. Electronic address: · Pubmed 29224780
2017
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
  • Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands. · Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Radiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands. · Pubmed 28790119
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Pubmed 28650484
  • Division of Molecular Pathology and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Division of Molecular Carcinogenesis and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Faculty of EEMCS, Delft University of Technology, Mekelweg 4, Delft 2628 CD, The Netherlands. · Pubmed 28575524
  • Department of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan, CX, Amsterdam, The Netherlands. · Current address: Merus B.V., Padualaan, CH Utrecht, The Netherlands. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan, CX, Amsterdam, The Netherlands. · Faculty of EEMCS Delft University of Technology, Delft, The Netherlands. · Broad Institute of Harvard & MIT, Cambridge, MA, USA. · Harvard Stem Cell Institute, Cambridge, MA, USA. · Harvard-Ludwig Center for Cancer Research, Boston, MA, USA. · Pubmed 28411283
  • Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Faculty of Electrical Engineering, Mathematics, and Computer Science, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Pubmed 28167798
2016
  • Division of Molecular Carcinogenesis and Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Wellcome Trust Sanger Institute, Cambridge, UK. · Pubmed 26923330
  • Division of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Section of Molecular Cytology and Van Leeuwenhoek Centre for Advanced Microscopy, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, the Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, 3584 CG Utrecht, the Netherlands. Electronic address: · Pubmed 27524621
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27197147
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Cancer Systems Biology Center (CSBC), The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. The NKI Robotics and Screening Center (NRSC), The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Cancer Systems Biology Center (CSBC), The Netherlands Cancer Institute, Amsterdam, the Netherlands. The NKI Robotics and Screening Center (NRSC), The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27196766
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Translational Breast Cancer Laboratory, Free University of Brussels, Institute Jules Bordet, Brussels, Belgium. · GBG German Breast Group, Neu Isenburg, Germany. · Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · Multidisciplinary Breast Center, KU Leuven, University Hospitals, Leuven, Belgium. · Department of Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27172896
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Agendia NV, Amsterdam, XH, The Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, GA, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Pathology, University Medical Center Utrecht, CX, The Netherlands. · Pubmed 27129152
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
2015
  • Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Genetics, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Mekelweg 4, 2628 CD, Delft, The Netherlands. · Pubmed 26433948
  • Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 26260527
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Agendia NV, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, The Netherlands. Electronic address: · Pubmed 26004083
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
  • Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Pubmed 25511378
2014
  • Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands. · Department of Bioinformatics and Statistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands. · Pubmed 25083859
  • Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Pubmed 24558399
2013
  • Authors' Affiliations: Department of Medical Oncology, Erasmus University Medical Center, Cancer Institute, Rotterdam; Departments of Molecular Carcinogenesis and Molecular Pathology, Central Genomic Facility, the Netherlands Cancer Institute; Agendia NV, Amsterdam, the Netherlands; and Translational Cancer Research Unit, Laboratory of Pathology, Antwerp University/Oncology Centre, GZA Hospitals St-Augustinus, Antwerp, Belgium. · Pubmed 24242068
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands, Division of Molecular Biology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands, Division of Medical Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands and Faculty of EEMCS, Delft University of Technology, 2628 CN, Delft, The Netherlands. · Pubmed 24062158
  • Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23828499
  • Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 23670131
  • Department of Molecular Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 23483055
  • Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23203637
2012
  • Department of Bioinformatics and Statistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 22796958
  • Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 22396490
2011
  • Department of Experimental Therapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 22032731
  • Divisions of Experimental Therapy, Molecular Biology, Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 21347257
  • Department of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 21286804
  • Division of Molecular Biology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 21135055
Probable:    Miscellaneous institutions in Utrecht      
2019
  • Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Utrecht, the Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, Ghent University Hospital, Ghent, Belgium. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · NanoString Technologies, Inc., Seattle, WA, USA. · Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium. · Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia. · Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 31086347
2018
  • Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center, 3584 CX, Utrecht, The Netherlands. · Dutch Breast Cancer Research Group, (BOOG Study Center), 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer Genomics Netherlands, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. · Department of Pathology, VU Medical Center (VUMC), 1081 HV, Amsterdam, The Netherlands. · Division of Oncology and Pathology, Lund University, 221 00, Lund, Sweden. · Department of Pathology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands. · Department of Pathology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Faculty of EEMCS, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 29396493
Probable:    Technische Universiteit Delft      
2018
  • Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Pubmed 30379847
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 30115694
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Genomic Sequencing Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Cancer and Haematology, The Walter and Eliza Hall Institute, Parkville Victoria, Australia. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Pubmed 29844118
  • Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center, 3584 CX, Utrecht, The Netherlands. · Dutch Breast Cancer Research Group, (BOOG Study Center), 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer Genomics Netherlands, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. · Department of Pathology, VU Medical Center (VUMC), 1081 HV, Amsterdam, The Netherlands. · Division of Oncology and Pathology, Lund University, 221 00, Lund, Sweden. · Department of Pathology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands. · Department of Pathology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Faculty of EEMCS, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 29396493
  • Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands. · Cell Screening Core, Department of Cell Biology, Center for Molecular Medicine, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Pharmacology and Translational Research, Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, 1121 Vienna, Austria. · Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands; Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Länggassstrasse 122, 3012 Bern, Switzerland. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. Electronic address: · Pubmed 29224780
2017
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Pubmed 28650484
  • Division of Molecular Pathology and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Division of Molecular Carcinogenesis and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Faculty of EEMCS, Delft University of Technology, Mekelweg 4, Delft 2628 CD, The Netherlands. · Pubmed 28575524
  • Department of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan, CX, Amsterdam, The Netherlands. · Current address: Merus B.V., Padualaan, CH Utrecht, The Netherlands. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan, CX, Amsterdam, The Netherlands. · Faculty of EEMCS Delft University of Technology, Delft, The Netherlands. · Broad Institute of Harvard & MIT, Cambridge, MA, USA. · Harvard Stem Cell Institute, Cambridge, MA, USA. · Harvard-Ludwig Center for Cancer Research, Boston, MA, USA. · Pubmed 28411283
  • Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Faculty of Electrical Engineering, Mathematics, and Computer Science, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Pubmed 28167798
2016
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27197147
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
2015
  • Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Genetics, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Mekelweg 4, 2628 CD, Delft, The Netherlands. · Pubmed 26433948
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
2014
  • Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands. · Department of Bioinformatics and Statistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands. · Pubmed 25083859
  • Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Pubmed 24558399
2013
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands, Division of Molecular Biology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands, Division of Medical Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands and Faculty of EEMCS, Delft University of Technology, 2628 CN, Delft, The Netherlands. · Pubmed 24062158
2012
  • Delft Bioinformatics Laboratory, Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Mekelweg, Delft, The Netherlands. · Pubmed 22808140
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 51 total) written by Lodewyk F. A. Wessels about Breast Neoplasms:

  • Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. 2019
  • Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer. 2019
  • Molecular characterization of breast and lung tumors by integration of multiple data types with functional sparse-factor analysis. 2018
  • Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547. 2018
  • Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality. 2018
  • Integrative Modeling Identifies Key Determinants of Inhibitor Sensitivity in Breast Cancer Cell Lines. 2018
  • MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models. 2018
  • Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer. 2018
  • Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance. 2018
  • A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. 2018
Show List of Full Article Records
Google Searches

Learn more about Lodewyk F. A. Wessels using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Leeuwenhoek Hospital
Miscellaneous institutions in Utrecht
Technische Universiteit Delft
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Leeuwenhoek Hospital
2019
  • Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Utrecht, the Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, Ghent University Hospital, Ghent, Belgium. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · NanoString Technologies, Inc., Seattle, WA, USA. · Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium. · Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia. · Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 31086347
  • Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Transgenic Core Facility, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · ACRF Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. · Department of Medical Biology, University of Melbourne, Parkville, VIC, 3010, Australia. · Preclinical Intervention Unit, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Medicine, University of Medicine, Parkville, VIC, 3010, Australia. · Parkville Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, VIC, 3050, Australia. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 30674894
2018
  • Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Pubmed 30379847
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 30115694
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden 2333 ZC, the Netherlands. · Institute of Molecular Cancer Research, University of Zurich, Zurich CH-8057, Switzerland. · Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9723GZ, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Division of Cell Biology and BioImaging Facility, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK. · Danish Cancer Society Research Center, Copenhagen 2100, Denmark; Karolinska Institute, Department of Medical Biochemistry and Biophysics, Division of Genome Biology, Science for Life Laboratory, Stockholm 171 77, Sweden. · Danish Cancer Society Research Center, Copenhagen 2100, Denmark. · Pathology Department, Complejo Hospt. Univ. Insular Materno Infantil, Las Palmas, Gran Canaria, Spain. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. Electronic address: · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern 3012, Switzerland. Electronic address: · Pubmed 29894693
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Genomic Sequencing Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Cancer and Haematology, The Walter and Eliza Hall Institute, Parkville Victoria, Australia. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Pubmed 29844118
  • Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 2QQ, UK. · Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Pubmed 29795445
  • Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center, 3584 CX, Utrecht, The Netherlands. · Dutch Breast Cancer Research Group, (BOOG Study Center), 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer Genomics Netherlands, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. · Department of Pathology, VU Medical Center (VUMC), 1081 HV, Amsterdam, The Netherlands. · Division of Oncology and Pathology, Lund University, 221 00, Lund, Sweden. · Department of Pathology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands. · Department of Pathology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Faculty of EEMCS, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 29396493
  • Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 29326437
  • Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands. · Cell Screening Core, Department of Cell Biology, Center for Molecular Medicine, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Pharmacology and Translational Research, Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, 1121 Vienna, Austria. · Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands; Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Länggassstrasse 122, 3012 Bern, Switzerland. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. Electronic address: · Pubmed 29224780
2017
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
  • Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands. · Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Radiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands. · Pubmed 28790119
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Pubmed 28650484
  • Division of Molecular Pathology and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Division of Molecular Carcinogenesis and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Faculty of EEMCS, Delft University of Technology, Mekelweg 4, Delft 2628 CD, The Netherlands. · Pubmed 28575524
  • Department of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan, CX, Amsterdam, The Netherlands. · Current address: Merus B.V., Padualaan, CH Utrecht, The Netherlands. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan, CX, Amsterdam, The Netherlands. · Faculty of EEMCS Delft University of Technology, Delft, The Netherlands. · Broad Institute of Harvard & MIT, Cambridge, MA, USA. · Harvard Stem Cell Institute, Cambridge, MA, USA. · Harvard-Ludwig Center for Cancer Research, Boston, MA, USA. · Pubmed 28411283
  • Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Faculty of Electrical Engineering, Mathematics, and Computer Science, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Pubmed 28167798
2016
  • Division of Molecular Carcinogenesis and Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Wellcome Trust Sanger Institute, Cambridge, UK. · Pubmed 26923330
  • Division of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Section of Molecular Cytology and Van Leeuwenhoek Centre for Advanced Microscopy, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, the Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, 3584 CG Utrecht, the Netherlands. Electronic address: · Pubmed 27524621
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27197147
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Cancer Systems Biology Center (CSBC), The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. The NKI Robotics and Screening Center (NRSC), The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Cancer Systems Biology Center (CSBC), The Netherlands Cancer Institute, Amsterdam, the Netherlands. The NKI Robotics and Screening Center (NRSC), The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27196766
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Translational Breast Cancer Laboratory, Free University of Brussels, Institute Jules Bordet, Brussels, Belgium. · GBG German Breast Group, Neu Isenburg, Germany. · Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · Multidisciplinary Breast Center, KU Leuven, University Hospitals, Leuven, Belgium. · Department of Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27172896
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Agendia NV, Amsterdam, XH, The Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, GA, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Pathology, University Medical Center Utrecht, CX, The Netherlands. · Pubmed 27129152
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
2015
  • Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Genetics, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Mekelweg 4, 2628 CD, Delft, The Netherlands. · Pubmed 26433948
  • Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 26260527
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Agendia NV, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, The Netherlands. Electronic address: · Pubmed 26004083
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
  • Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Pubmed 25511378
2014
  • Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands. · Department of Bioinformatics and Statistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands. · Pubmed 25083859
  • Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Pubmed 24558399
2013
  • Authors' Affiliations: Department of Medical Oncology, Erasmus University Medical Center, Cancer Institute, Rotterdam; Departments of Molecular Carcinogenesis and Molecular Pathology, Central Genomic Facility, the Netherlands Cancer Institute; Agendia NV, Amsterdam, the Netherlands; and Translational Cancer Research Unit, Laboratory of Pathology, Antwerp University/Oncology Centre, GZA Hospitals St-Augustinus, Antwerp, Belgium. · Pubmed 24242068
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands, Division of Molecular Biology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands, Division of Medical Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands and Faculty of EEMCS, Delft University of Technology, 2628 CN, Delft, The Netherlands. · Pubmed 24062158
  • Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23828499
  • Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 23670131
  • Department of Molecular Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 23483055
  • Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23203637
2012
  • Department of Bioinformatics and Statistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 22796958
  • Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 22396490
2011
  • Department of Experimental Therapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 22032731
  • Divisions of Experimental Therapy, Molecular Biology, Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 21347257
  • Department of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 21286804
  • Division of Molecular Biology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 21135055
Miscellaneous institutions in Utrecht
2019
  • Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Utrecht, the Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, Ghent University Hospital, Ghent, Belgium. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · NanoString Technologies, Inc., Seattle, WA, USA. · Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium. · Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia. · Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 31086347
2018
  • Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center, 3584 CX, Utrecht, The Netherlands. · Dutch Breast Cancer Research Group, (BOOG Study Center), 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer Genomics Netherlands, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. · Department of Pathology, VU Medical Center (VUMC), 1081 HV, Amsterdam, The Netherlands. · Division of Oncology and Pathology, Lund University, 221 00, Lund, Sweden. · Department of Pathology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands. · Department of Pathology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Faculty of EEMCS, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 29396493
Technische Universiteit Delft
2018
  • Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Pubmed 30379847
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 30115694
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Genomic Sequencing Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Cancer and Haematology, The Walter and Eliza Hall Institute, Parkville Victoria, Australia. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Pubmed 29844118
  • Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center, 3584 CX, Utrecht, The Netherlands. · Dutch Breast Cancer Research Group, (BOOG Study Center), 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer Genomics Netherlands, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. · Department of Pathology, VU Medical Center (VUMC), 1081 HV, Amsterdam, The Netherlands. · Division of Oncology and Pathology, Lund University, 221 00, Lund, Sweden. · Department of Pathology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands. · Department of Pathology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Faculty of EEMCS, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 29396493
  • Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands. · Cell Screening Core, Department of Cell Biology, Center for Molecular Medicine, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Pharmacology and Translational Research, Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, 1121 Vienna, Austria. · Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands; Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Länggassstrasse 122, 3012 Bern, Switzerland. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. Electronic address: · Pubmed 29224780
2017
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Pubmed 28650484
  • Division of Molecular Pathology and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Division of Molecular Carcinogenesis and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Faculty of EEMCS, Delft University of Technology, Mekelweg 4, Delft 2628 CD, The Netherlands. · Pubmed 28575524
  • Department of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan, CX, Amsterdam, The Netherlands. · Current address: Merus B.V., Padualaan, CH Utrecht, The Netherlands. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan, CX, Amsterdam, The Netherlands. · Faculty of EEMCS Delft University of Technology, Delft, The Netherlands. · Broad Institute of Harvard & MIT, Cambridge, MA, USA. · Harvard Stem Cell Institute, Cambridge, MA, USA. · Harvard-Ludwig Center for Cancer Research, Boston, MA, USA. · Pubmed 28411283
  • Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Faculty of Electrical Engineering, Mathematics, and Computer Science, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Pubmed 28167798
2016
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27197147
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
2015
  • Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Genetics, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Medical Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Amsterdam, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Mekelweg 4, 2628 CD, Delft, The Netherlands. · Pubmed 26433948
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
2014
  • Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands. · Department of Bioinformatics and Statistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands. · Pubmed 25083859
  • Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Pubmed 24558399
2013
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands, Division of Molecular Biology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands, Division of Medical Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands and Faculty of EEMCS, Delft University of Technology, 2628 CN, Delft, The Netherlands. · Pubmed 24062158
2012
  • Delft Bioinformatics Laboratory, Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Mekelweg, Delft, The Netherlands. · Pubmed 22808140
Miscellaneous cities in Netherlands
2014
  • Authors' Affiliations: Division of Molecular Carcinogenesis and Cancer Genomics Center Netherlands; and. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands · Authors' Affiliations: Division of Molecular Carcinogenesis and Cancer Genomics Center Netherlands; and · Pubmed 25028367
2012
  • Centrum Wiskunde & Informatica, Life Sciences Group, The Netherlands. · Pubmed 22558100
6 Other Locations Show
Yearly article counts 28675675500
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.